期刊文献+

马钱子碱白蛋白纳米粒的制备与初步评价 被引量:7

Evaluation and Preparation of Brucine-BSA-NPs
下载PDF
导出
摘要 目的制备马钱子碱白蛋白纳米粒,并考察其体外理化性质。方法采用去溶剂化-化学交联法制备白蛋白纳米粒。利用透射电镜、马尔文激光粒度仪、HPLC法及考马斯亮兰-酶标仪对制备的纳米粒进行表征。结果制得的纳米粒呈类球形,平均粒径为(209.8±3.6)nm,Zeta电位(-34.49±1.32)mV,纳米粒收率90.0%±3.2%,包封率为60%±2.3%,载药量为2%±1.2%,体外模拟释药结果表明载药纳米粒药物释放速率在24h内持续稳定。结论去溶剂化-化学交联法制备马钱子碱白蛋白纳米粒简便可靠,体外释药具有明显的缓释作用。 OBJECTIVE To prepare Brucine-BSA-NPs and to observe its physicochemical property in vitro.METHODS Brucine-BSA-NPs was prepared by using desolvation-crosslinking method,and characterized by TEM,Zetasizer 3000HS,HPLC,and Coomassie brilliant blue-enzyme-labeled instrument.RESULTS The prepared Brucine-BSA-NPs was round with average diameter of(209.8±3.6) nm,Zeta potential of(-34.49±1.32) mV,90.0%±3.2% yield,encapsulation rate of 60%±2.3%,and drug loading of 2%±1.2%.The results of modeling drug release in vitro illustrated the releasing rate of Brucine-BSA-NPs with loaded drug was continuously stable in 24 h.CONCLUSION Applying desolvation-crosslinking method to prepare Brucine-BSA-NPs is convenient and reliable,showing conspicuous sustained release of drug in vitro.
出处 《南京中医药大学学报》 CAS CSCD 北大核心 2011年第6期555-557,共3页 Journal of Nanjing University of Traditional Chinese Medicine
基金 国家教育部新教师基金(20093237120016) 南京中医药大学重点培育课题
关键词 马钱子碱 白蛋白纳米粒 去溶剂化-化学交联法 体外释放 Brucine BSA-NPs desolvation-crosslinking method release in vitro
  • 相关文献

参考文献3

二级参考文献26

  • 1黄瑾,胡晋红,邱磊,蔡溱.阿魏酸钠抑制肝星状细胞合成胶原的机制[J].药学学报,2004,38(8):577-580. 被引量:14
  • 2李凤前,胡晋红.抗肝纤维化中药制剂的研究概况[J].药学服务与研究,2004,4(3):230-233. 被引量:2
  • 3Janes KA, Fresneau MP, Marazuela A, et al. Chitosan nanoparticles as delivery systems for doxorubiein [ J ] . J Controlled Release, 2001 , 73 ( 2-3) :255 - 267.
  • 4Kun N, Eun SL, You HB. Adriamycin loaded pullunlan acetate/sulgonamide conjugate nanoparticles responding to tumor pH: pH-dependent cell interaction, internalization and cytotoxicity in vitro[J]. J Controlled Release ,2003,87(1-3) :3 - 13.
  • 5Na K, Bum LT, Park KH, et al. Self-assembled nanoparticles of hydrophobically-modified polysaccharide beating vitamin H as a targeted anti-cancer drug delivery system[ J ]. Eur J Pharm Sci, 2003,18(2) :165 - 173.
  • 6Jung HH,Yu KO, Kim DS, et al. Enhanced hepatocyre uptake and liver targeting of methotrexate using galaetasylated albumin as a carrier[J].Int J Pharm, 1999,188( 1 ) :39 - 47.
  • 7Sudimack-Lee RJ.Targeted drug delivery via tile folate receptor[J]. Adv Drag Deliv Rev,2000,41(2):147.
  • 8Lee RJ,Low PS.Delivery of liposmes into cultured KB cells via folate receptor-mediated endocytosis[J].J Biol Chem.1994.269(5):3198.
  • 9Jameela SR,Jayakrislman A.Glutaraldehyde cross-linked chitosan, microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle [J].Biomaterials.1995,16 (10):769.
  • 10Lin W, Garnett MC, Schacht E, et al. Preparation and in vitro characterization of HSA mPEG nanoparticles [J]. Int J Pharm, 1999,189(2): 161.

共引文献11

同被引文献138

引证文献7

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部